Health ❯ Vaccines

Influenza Vaccines

mRNA Vaccines Availability Comparative Effectiveness Thimerosal Market Dynamics COVID-19 Vaccines H5N1 Vaccine Vaccine Uptake Sales Trends FluMist

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

The agency said the Phase 3 control for seniors did not reflect the U.S. best standard of care, a rare procedural rebuke that Moderna disputes.

Dupixent Powers Sanofi’s Q3 as Vaccine Sales Slip

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval